BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Talks.cam//talks.cam.ac.uk//
X-WR-CALNAME:Talks.cam
BEGIN:VEVENT
SUMMARY:Stem Cells and Bioprocessing - www.regonline.co.uk/StemBio2014
DTSTART:20140603T080000Z
DTEND:20140603T160000Z
UID:TALK51758@talks.cam.ac.uk
CONTACT:Speaker to be confirmed
DESCRIPTION:Harnessing the immense therapeutic and research potential of s
 tem cells requires extensive quality control to ensure the identity\, qual
 ity\, and safety of the cell. Stem cells of different origin and their cap
 ability to differentiate towards a specific phenotype as well as tissue en
 gineered constructs are dependent of all kinds of bioprocesses including c
 ultivation media\, biomechanical conditions and purification techniques. A
 ll topics dealing with the optimization and analysis of processes leading 
 to defined in vitro cultivated cell lines and engineered tissues - with a 
 special focus on bioreactors - will be discussed in this session. This eve
 nt has CPD accreditation.\n\nTo view the pdf agenda please click on \nhttp
 ://lifescienceevents.com/wp-content/uploads/3rdJuneStemBiop2014.pdf\n\nThi
 s event is part of The 2014 Tissue Engineering Congress\n\n*Meeting Chair*
 : Dr Johanna Buschmann\, Head of Research Laboratories\, University Hospit
 al Zurich\, Plastic Surgery\, Switzerland\n\n*Who Should Attend*: All thos
 e interested in the use of stem cells for tissue engineered constructs sho
 uld find this meeting extremely valuable.\n\nThe deadline for abstract sub
 missions for oral presentation is March 10th 2014. Abstracts for poster pr
 esentation only can be submitted up to two weeks before the event. You can
  download the instructions for authors at: www.euroscicon.com/AbstractsFor
 OralAndPosterPresentation.pdf\n\n*Talks include*\nProliferation of ASC-der
 ived endothelial cells in a 3D electrospun mesh: Impact of bone-biomimetic
  nanocomposite and co-culture with ASC-derived osteoblasts.\nDr Johanna Bu
 schmann\, Head of Research Laboratories\, University Hospital Zurich\, Pla
 stic Surgery\, Switzerland\n\nBioreactors for tissue engineering\nDr Maria
 nne Ellis\, University of Bath\, UK\n\nDevelopment of scalable microcarrie
 r-based tissue engineering\nDr Ivan Wall\, Lecturer in Regenerative Medici
 ne Bioprocessing\, University College London\, UK\n\nImmune Regulation by 
 Mesenchymal Stromal Cells from Umbilical Cord\nDr John Girdlestone\, NHS B
 lood and Transplant\, UK\n\nAdditional confirmed speakers\nProfessor Athan
 asios Mantalaris\, Imperial College London\, UK\nDr Farlan Veraitch\, Depa
 rtment of Biochemical Engineering\, University College London\, UK\n\n \nK
 eywords: Clinical Trial Partnerships\, stem cells\, banking\,manufacturing
 \,scale-up\,GMP\, regenerative\,IPS\, ATMPs\, somatic\, stem cells\, const
 ructs\, human embryonic stem cells\, clinical grade\, cGMP\, macular degen
 eration\, retinal pigment epithelium\, RPE\, AMD\, multiple sclerosis\, ne
 urodegeneration\,cell therapy\, clinician-scientist\, stem cell research\,
  translation\, career path\, Stem Cells\, Embryonic\, clinical application
 \,  Manufacture\, Cell Therapies\, Process\,umbilical cord\; cord blood\; 
 mesenchymal\; biobanking\; cell therapy\, Stem cell\, dynamic culture\, di
 fferentiation\, biomechanics\, bioreactor\, Biochemical Engineering\; Bior
 eactors\; Bone Regeneration\; Cultured Meat\; Liver Toxicity Mode
LOCATION:Cineworld: The O2\, Peninsula Square\, London\, SE10 0DX
END:VEVENT
END:VCALENDAR
